Global Theranostics Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities

The Theranostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Theranostics Market Size Expected to Be by 2034?
The Theranostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Theranostics Market Size Expected to Be by 2034?

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10823

What Are the Emerging Segments Within the Theranostics Market?
The theranostics market covered in this report is segmented -

1) By Disease Type: Neurological Disorders, Cardiovascular Diseases, Immunological Disorders, Oncology Diseases, Other Diseases
2) By Technology: Polymerase Chain Reaction, Immunohistochemistry, In-Situ Hybridization, Sequencing, Other Technologies
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:
1) By Neurological Disorders: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Epilepsy, Other Neurological Disorders
2) By Cardiovascular Diseases: Coronary Artery Disease, Heart Failure, Atrial Fibrillation, Hypertension, Other Cardiovascular Diseases
3) By Immunological Disorders: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Inflammatory Bowel Disease, Psoriasis, Other Immunological Disorders
4) By Oncology Diseases: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Oncology Diseases
5) By Other Diseases: Infectious Diseases, Metabolic Disorders, Genetic Disorders, Other Diseases

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10823&type=smp

What Long-Term Drivers Are Shaping Theranostics Market Trends?
The growth of the theranostics market is anticipated to be driven by the increasing incidence of cancer. Cancer is a disease characterized by abnormal cell growth which affects different organs and leads to critical morbidity and death globally. Theranostics, a field combining diagnostics with therapeutics, holds significant potential in addressing cancer and chronic diseases. It paves the way for tailored treatments through the fusion of diagnostic and therapeutic aspects, fostering innovation within the healthcare sector. Thus, the rising number of cancer patients is likely to encourage the progression of the theranostics market. As an example, the National Cancer Institute (NCI), a U.S.-based governmental institution affiliated with the National Institutes of Health (NIH) engaged in cancer research, prevention, and treatment, reported in January 2022 that about 5.4% of the U.S. population, or 18.1 million individuals, have survived cancer. Coupled with this, there have been 623,405 individuals with metastasized breast, prostate, lung, colorectal, or bladder cancer, or metastasized melanoma in 2022, a figure expected to escalate to 693,452 by 2025. Thus, the increasing frequency of cancer serves as a catalyst for the theranostics market's growth.

Who Are the Top Competitors in Key Theranostics Market Segments?
Major companies operating in the theranostics market include Abbott Laboratories, Agilent Technologies Inc., AmeriPath Inc, Beckman Coulter Inc., Thermo Fisher Scientific Inc, Astellas Pharma, Helmholtz Centre for Infection Research, Radiopharm Theranostics Ltd, Alpha- Theranostics, UNIVERZITET U NOVOM SADU, Cardio-Theranostics LLC, Curium, SoFi Technologies Inc., Theradiag, Cell Theranostics, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc, Qiagen NV, Foundation Medicine Inc, Leica Biosystems Nussloch GmBH, Pfizer Inc., Siemens Healthineers, Advanced Accelerator Applications, AstraZeneca plc, Bayer AG, Bio-Rad Laboratories, The Bristol-Myers Squibb Company, Danaher Corporation, MilliporeSigma, Illumina Inc., Merck KGaA, Roche Diagnostics Corporation, PerkinElmer Inc.

What Theranostics Market Trends Are Gaining Traction Across Different Segments?
Companies leading the theranostics market are concentrating on creating advanced solutions like theranostics clinical trials. This aims to augment personalised medicine and enhance patient results by combining diagnostics and treatments into one method. They are research studies that assess the collective use of targeted treatments and diagnostic tests to personalise treatment plans for each patient. The goal of these trials is to find out how effective unique treatments are, based on biomarkers specific to the patient, thus boosting personalised medicine. For example, BAMF Health, a cancer treatment centre located in the US, initiated the COMBAT Trial, properly known as "A Phase I/II Theranostic Study of 64Cu-SAR-BBN and 67Cu-SAR-BBN for Identification and Treatment of GRPR-expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617" (NCT05633160), in May 2024. The trial was able to begin within seven weeks due to BAMF Health's fast-acting BAMF RapAct programme and focuses on using new radiopharmaceuticals that target the Gastrin-Releasing Peptide receptor (GRPR). This could potentially enhance treatment options for patients who have limited therapeutic choices.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/theranostics-global-market-report

Which Regions Are Becoming Hubs for Theranostics Market Innovation?
North America was the largest region in the global theranostics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the theranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Theranostics Market?
2. What is the CAGR expected in the Theranostics Market?
3. What Are the Key Innovations Transforming the Theranostics Industry?
4. Which Region Is Leading the Theranostics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.